Insider schedules modest 240-share ONTF (NASDAQ: ONTF) sale via Rule 144
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
An affiliated holder of ONTF common stock filed a Rule 144 notice to sell 240 shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of 1903.54. The issuer had 42282395 common shares outstanding when this notice was prepared.
The 240 shares were acquired on 02/10/2026 as performance shares from the issuer, with the same date shown for payment. Over the prior three months, James Blackie sold additional common shares in several transactions, with gross proceeds of 127360.00, 62011.13, 66057.46, and 24682.45. The seller represents they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
FAQ
What does the ONTF Form 144 filing disclose about the new planned stock sale?
The filing shows an affiliated holder plans to sell 240 ONTF common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of 1903.54. These shares were acquired as performance shares on 02/10/2026 from the issuer.
What recent ONTF stock sales by James Blackie are listed in the Rule 144 notice?
The notice lists James Blackie selling ONTF common shares on 11/20/2025, 12/01/2025, 12/02/2025, and 12/30/2025, with amounts of 4659, 11599, 10951, and 16000 shares and gross proceeds of 24682.45 to 127360.00.
What representation does the ONTF Rule 144 seller make about inside information?
The seller represents that they do not know any material adverse information about the current or prospective operations of the issuer that has not been publicly disclosed. This statement is required when filing a Rule 144 notice for the planned sale of restricted or control securities.
Which broker is handling the ONTF Rule 144 sale and on which exchange?
The Rule 144 notice identifies Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the ONTF trade. The planned sale of 240 common shares is expected to occur on the NYSE, with an approximate sale date of 02/10/2026.